With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.166330-10-5,(Oxybis(2,1-phenylene))bis(diphenylphosphine),as a common compound, the synthetic route is as follows.
General procedure: Dpa (0.0368 g, 0.2 mmol) and POP (0.0539 g, 0.1 mmol) wereadded into the stirring solution of AgClO4 (0.0208 g, 0.1 mmol),in a mixture of CH3CN (5 ml) and H2O (5 ml) at ambient temperature.The mixture was stirred for 6 h. The insoluble residues wereremoved by filtration, and the brown filtrate was evaporatedslowly at room temperature for about four days to yield whitecrystals. Yields: 42percent., 166330-10-5
As the paragraph descriping shows that 166330-10-5 is playing an increasingly important role.
Reference£º
Article; Zhang, Yan-Ru; Cui, Yang-Zhe; Jin, Qiong-Hua; Yang, Yu-Ping; Liu, Min; Li, Zhong-Feng; Bi, Kai-Lun; Zhang, Cun-Lin; Polyhedron; vol. 122; (2017); p. 86 – 98;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate